Semaglutide is a GLP-1 agonist, Tirzepatide is a dual GLP-1 and GIP agonist, and Retatrutide is a triple GLP-1, GIP, and glucagon agonist
Regular physical activity helps improve insulin sensitivity, control weight, and reduce cardiovascular risk factors
Trusted by Indias Leading Brands
It can aid in weight management is by improving metabolic health by reducing inflammation and oxidative stress, enhancing workout recovery, and improving gut health and function
Medicare may cover Mounjaro for people who have Type 2 diabetes, but not for weight loss or obstructive sleep apnea
Individuals should notify their healthcare provider if they experience any unexpected changes or prolonged periods without noticeable effects